Across two decades in genetic research, healthcare marketing, and advertising, RJ saw the same pattern repeatedly. Brands invest heavily in research, strategy, and activation. Insight is abundant. AI now generates ideas at speed.

But precision is rarer.

The harder, more valuable work is identifying the few salient defaults inside real-world practice that actually sustain clinical behavior — and designing the precise interventions that reshape them.

Silbospark works with rare and specialty brands — small, defined populations where the clinical behaviors that drive a brand are more nuanced, and the margin for generic tactics is smaller.